Panel Discussion: (Long-Acting Injectables: The New Frontier in Global Health). Moderator: Tomas Cihlar (Senior Vice President, Virology Research, Gilead Sciences, Inc., United States); Lluís Ballell (Executive Director, Compound Development Team Leader, Johnson & Johnson Innovative Medicine, Belgium); Cristina Donini (Executive Vice President, Head of Research & Development, Medicines for Malaria Venture, Switzerland).
Experts in HIV, TB, and malaria explore how long-acting injectable formulations - building on breakthroughs in HIV prevention - could transform treatment and prevention across infectious diseases.
From the 2026 meeting in London, United Kingdom
Jun 19, 2026